ChemCom
2000
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
$1.23M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of olfactory and taste receptors designed to offer services related to olfaction, taste and pheromonal communications in human. The company's receptors develop products based on chemo-sensory technology such as taste, olfaction, pheromones for human, mammals and insects, enabling users to get a diverse range of flavors & fragrances.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Consumer Products and Services
Primary Office
- Route de Lennik 802
- 1070 Brussels
- Belgium
+32 02 000 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore ChemCom’s full profile, request a free trial.
ChemCom Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 30-Dec-2014 | $1.23M | 00.000 | 000.00 | Completed | |
| 5. Later Stage VC | 23-Sep-2011 | 00000 | 00.000 | 000.00 | Completed | |
| 4. Early Stage VC | 11-Oct-2005 | 00.000 | 00.000 | 00.00 | Completed | |
| 3. Early Stage VC | 08-Sep-2004 | 00.000 | 00.000 | 00.000 | Completed | |
| 2. Early Stage VC | 15-Apr-2003 | $1.07M | $1.51M | 00.000 | Completed | |
| 1. Capitalization | 12-Oct-2000 | $435K | $435K | Completed | Generating Revenue |
ChemCom Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Class D | 00,000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | ||
| Class C | 00,000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | ||
| Class B | 37,500 | $24.62 | $24.62 | 1x | $24.62 | 14.94% | ||
| Class A | 37,500 | $24.62 | $24.62 | 1x | $24.62 | 14.94% |
ChemCom Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Biotec | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Florinvest | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
ChemCom Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Christian Osselaer Ph.D | Founder & Chief Executive Officer | ||
| Yannick Quesnel | CSO | ||
| Pierre Chatelain Ph.D | Member of Executive Committee |
ChemCom Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Gaetan Waucquez | Self | Non-Executive Director | 000 0000 | |
| Jacques Dumont Ph.D | Self | Non-Executive Director and Scientific Advisor | 000 0000 | |
| Jean-Marie Delwart | Self | Chairman | 000 0000 | |
| Marc Parmentier Ph.D | Self | Non-Executive Director and Scientific Adviser | 000 0000 | |
| Nathalie Delwart | ChemCom | Non-Executive Director | 000 0000 |